ctrl K

Watchlist Price Alert

ArriVent BioPharma Inc. C... (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

19.80

-1.01 (-4.85%)

At close: May 06, 2025, 3:59 PM

19.69

-0.56%

After-hours: May 06, 2025, 04:01 PM EDT

ArriVent BioPharma Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-94.31M	-74.59M	-36.91M	-8.7M
Interest Income	13.82M	5.26M	n/a	n/a
Pretax Income	-80.49M	-69.33M	-36.91M	-51.61M
Net Income	-80.49M	-69.33M	-36.91M	-51.61M
Selling & General & Admin	15.3M	9.71M	6.47M	2.26M
Research & Development	79M	64.88M	30.43M	6.43M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	94.31M	74.59M	36.91M	8.7M
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	-754K
Cost & Expenses	n/a	74.59M	36.91M	8.7M
Income Tax Expense	n/a	n/a	-36.91M	-11.59M
Shares Outstanding (Basic)	31.47M	31.96M	33.49M	33.49M
Shares Outstanding (Diluted)	31.47M	31.96M	33.49M	33.49M
EPS (Basic)	-2.56	-2.17	-1.1	-1.54
EPS (Diluted)	-2.56	-2.17	-1.1	-1.54
EBITDA	-80.49M	-74.59M	-36.91M	-51.61M
EBIT	n/a	-74.59M	-36.91M	-11.59M
Depreciation & Amortization	n/a	n/a	36.91M	11.59M